These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 28126883

  • 1. Prognostic Value of Bone Marrow Tracer Uptake Pattern in Baseline PET Scans in Hodgkin Lymphoma: Results from an International Collaborative Study.
    Zwarthoed C, El-Galaly TC, Canepari M, Ouvrier MJ, Viotti J, Ettaiche M, Viviani S, Rigacci L, Trentin L, Rusconi C, Luminari S, Cantonetti M, Bolis S, Borra A, Darcourt J, Salvi F, Subocz E, Tajer J, Kulikowski W, Malkowski B, Zaucha JM, Gallamini A.
    J Nucl Med; 2017 Aug; 58(8):1249-1254. PubMed ID: 28126883
    [Abstract] [Full Text] [Related]

  • 2. [Diagnostic and Prognostic Value of 18F-FDG PET/CT in Bone Marrow Infiltration of Newly Diagnosed Diffuse Large B-Cell Lymphoma].
    Chen X, Qiao WL, Song JH, Liu CC, Han L, Wu S, Zhao JH.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):1044-1049. PubMed ID: 37551475
    [Abstract] [Full Text] [Related]

  • 3. [Prognostic value of bone marrow (18)F-FDG uptake pattern of pretreatment PET-CT in extranodal NK/T cell lymphoma].
    Zhang Y, Zhou J, Wang L, Li JY, Ding CY.
    Zhonghua Zhong Liu Za Zhi; 2020 Oct 23; 42(10):885-890. PubMed ID: 33113633
    [Abstract] [Full Text] [Related]

  • 4. Prognostic Value of Bone Marrow FDG Uptake Pattern of PET/CT in Newly Diagnosed Diffuse Large B-cell Lymphoma.
    Chen Y, Zhou M, Liu J, Huang G.
    J Cancer; 2018 Oct 23; 9(7):1231-1238. PubMed ID: 29675104
    [Abstract] [Full Text] [Related]

  • 5. 18F-FDG PET-CT imaging versus bone marrow biopsy in pediatric Hodgkin's lymphoma: a quantitative assessment of marrow uptake and novel insights into clinical implications of marrow involvement.
    Hassan A, Siddique M, Bashir H, Riaz S, Wali R, Mahreen A, Nawaz MK.
    Eur J Nucl Med Mol Imaging; 2017 Jul 23; 44(7):1198-1206. PubMed ID: 28229191
    [Abstract] [Full Text] [Related]

  • 6. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.
    Berthet L, Cochet A, Kanoun S, Berriolo-Riedinger A, Humbert O, Toubeau M, Dygai-Cochet I, Legouge C, Casasnovas O, Brunotte F.
    J Nucl Med; 2013 Aug 23; 54(8):1244-50. PubMed ID: 23674577
    [Abstract] [Full Text] [Related]

  • 7. Analysis of 18F-FDG PET diffuse bone marrow uptake and splenic uptake in staging of Hodgkin's lymphoma: a reflection of disease infiltration or just inflammation?
    Salaun PY, Gastinne T, Bodet-Milin C, Campion L, Cambefort P, Moreau A, Le Gouill S, Berthou C, Moreau P, Kraeber-Bodéré F.
    Eur J Nucl Med Mol Imaging; 2009 Nov 23; 36(11):1813-21. PubMed ID: 19499219
    [Abstract] [Full Text] [Related]

  • 8. Prognostic Importance of Bone Marrow Uptake on Baseline 18F-FDG Positron Emission Tomography in Diffuse Large B Cell Lymphoma.
    Soydal C, Koksoy EB, Yasar A, Turgal E, Erdogan BD, Akbulut H, Kucuk NO.
    Cancer Biother Radiopharm; 2016 Dec 23; 31(10):361-365. PubMed ID: 27996313
    [Abstract] [Full Text] [Related]

  • 9. [The Value of Baseline PET/CT Imaging of Bone Marrow 18F-FDG Uptake Pattern in Predicting Prognosis of DLBCL].
    Wang Y, Zhao M, Yuan L, Li J.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr 23; 32(2):439-444. PubMed ID: 38660849
    [Abstract] [Full Text] [Related]

  • 10. Healthy tissue metabolism assessed by [18F]FDG PET/CT as a marker of prognosis and adverse events in advanced Hodgkin lymphoma patients.
    Malaih AA, Kirkwood AA, Johnson P, Radhakrishnan V, Fischer BM, Barrington SF.
    Sci Rep; 2024 Jun 01; 14(1):12613. PubMed ID: 38824206
    [Abstract] [Full Text] [Related]

  • 11. Characterizing bone marrow involvement in Hodgkin's lymphoma by FDG-PET/CT.
    Weiler-Sagie M, Kagna O, Dann EJ, Ben-Barak A, Israel O.
    Eur J Nucl Med Mol Imaging; 2014 Jun 01; 41(6):1133-40. PubMed ID: 24570095
    [Abstract] [Full Text] [Related]

  • 12. Variety in bone marrow 18F-FDG uptake in Hodgkin lymphoma patients without lymphomatous bone marrow involvement: does it have an explanation?
    Adams HJ, de Klerk JM, Fijnheer R, Heggelman BG, Dubois SV, Nievelstein RA, Kwee TC.
    Nucl Med Commun; 2016 Jan 01; 37(1):23-9. PubMed ID: 26440567
    [Abstract] [Full Text] [Related]

  • 13. Utility of 18F-fluorodeoxyglucose PET-CT scan in detecting bone marrow involvement in lymphoma.
    Jitani AK, Dutta S, Mandal PK, De R, Jajodia E, Baul S, Chakrabarti P, Dolai TK.
    Indian J Med Res; 2021 May 01; 154(5):691-698. PubMed ID: 35532587
    [Abstract] [Full Text] [Related]

  • 14. Diagnosis of bone marrow involvement in angioimmunoblastic T-cell lymphoma should be based on both [18F]FDG-PET/CT and bone marrow biopsy findings.
    Liang X, Yang C, Su M, Zou L.
    Curr Med Res Opin; 2024 May 01; 40(5):803-811. PubMed ID: 38626218
    [Abstract] [Full Text] [Related]

  • 15. 18F-FDG PET after 2 cycles of ABVD predicts event-free survival in early and advanced Hodgkin lymphoma.
    Cerci JJ, Pracchia LF, Linardi CC, Pitella FA, Delbeke D, Izaki M, Trindade E, Soares J, Buccheri V, Meneghetti JC.
    J Nucl Med; 2010 Sep 01; 51(9):1337-43. PubMed ID: 20720036
    [Abstract] [Full Text] [Related]

  • 16. [18F]Fluorodeoxyglucose positron emission tomography for detection of bone marrow involvement in children and adolescents with Hodgkin's lymphoma.
    Purz S, Mauz-Körholz C, Körholz D, Hasenclever D, Krausse A, Sorge I, Ruschke K, Stiefel M, Amthauer H, Schober O, Kranert WT, Weber WA, Haberkorn U, Hundsdörfer P, Ehlert K, Becker M, Rössler J, Kulozik AE, Sabri O, Kluge R.
    J Clin Oncol; 2011 Sep 10; 29(26):3523-8. PubMed ID: 21825262
    [Abstract] [Full Text] [Related]

  • 17. (18)F-FDG PET/CT bone/bone marrow findings in Hodgkin's lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging.
    Moulin-Romsee G, Hindié E, Cuenca X, Brice P, Decaudin D, Bénamor M, Brière J, Anitei M, Filmont JE, Sibon D, de Kerviler E, Moretti JL.
    Eur J Nucl Med Mol Imaging; 2010 Jun 10; 37(6):1095-105. PubMed ID: 20204358
    [Abstract] [Full Text] [Related]

  • 18. Focal skeletal FDG uptake indicates poor prognosis in cHL regardless of extent and first-line chemotherapy.
    Pedersen MA, Gormsen LC, Kamper P, Wassberg C, Andersen MD, d'Amore AL, Barrington SF, Johnson P, Hamilton-Dutoit S, Amini RM, Enblad G, Molin D, d'Amore F.
    Br J Haematol; 2019 Aug 10; 186(3):431-439. PubMed ID: 31115045
    [Abstract] [Full Text] [Related]

  • 19. Paediatric and adolescent Hodgkin lymphoma: information derived from diffuse organ uptake of 18 F-fluorodeoxyglucose on pre-treatment and on interim PET/CT.
    Jorgov L, Montravers F, Balogova S, Ragu C, Pacquement H, Leblanc T, Abbou S, Ducou-Lepointe H, Landman-Parker J, Talbot JN.
    Eur J Nucl Med Mol Imaging; 2016 Jul 10; 43(7):1220-30. PubMed ID: 26660144
    [Abstract] [Full Text] [Related]

  • 20. Post-ABVD/pre-radiotherapy (18)F-FDG-PET provides additional prognostic information for early-stage Hodgkin lymphoma: a retrospective analysis on 165 patients.
    Ciammella P, Filippi AR, Simontacchi G, Buglione M, Botto B, Mangoni M, Iotti C, Merli F, Marcheselli L, Bisi G, Ricardi U, Versari A.
    Br J Radiol; 2016 Jul 10; 89(1061):20150983. PubMed ID: 27022777
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.